商標ウォッチ

公開日2025-03-12
公報種別公開国際商標公報
国際登録番号1831761
国際登録日2024-06-04
区分第9類(機械器具),第35類(広告・事務),第41類(教育・娯楽),第42類(科学・技術)
商品役務Downloadable, web-based, and recorded software for computers and handheld computers, namely, downloadable, web-based and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for data collection for use in clinical trials; downloadable, web-based 全 261 件を表示, and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information for use in clinical trials; downloadable, web-based, and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for the collection, editing, organizing, modifying, book marking, transmission, storage, sharing of data information, patient reported outcomes and clinical outcomes and assessments, on computing devices; downloadable, web-based, and recorded software for the capture, reporting, and processing of data in pharmaceutical industry clinical trials; downloadable, web-based, and recorded software for enabling the capture, reporting, and processing of clinical outcomes assessments in pharmaceutical industry clinical trials; downloadable, web-based, and recorded application patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for use in pharmaceutical industry clinical trials to facilitate the generation and collection of patient reported outcomes by encouraging patient engagement and compliance using notifications, in particular, device, text message and email reminders, and securing collection of data online or offline; downloadable, web-based, and recorded software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, all of which information is added to existing study questionnaires as a way to record concomitant medications (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); downloadable, web-based, and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for conveying to patients information related to a clinical trial using interactive multimedia and for enabling patients to dynamically engage, review, question and agree to participate in a clinical trial, using tiered information delivery, interactive assessments, interactive communication of questions to the clinical trial staff, and to generate information and reports, and using a development platform allowing users to collaboratively design and develop content across multiple stakeholders; downloadable, web-based, and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software for maintaining and tracking of personal medical files; downloadable, web-based, and recorded patient engagement and communication software, pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software, subject measurement and testing software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software to plan, monitor and control the clinical supply chain; downloadable, web-based, and recorded computer programs for use in connection with data networks for use helping patients and doctors manage diabetes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); recorded software and applications for use in database management and support for use in data collection in connection with clinical trials.,Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, customize ratings reliability activities (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for business purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database in the field of clinical trials for business purposes featuring business information on complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for business purposes designed to monitor and provide real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database in the field of clinical trials for business purposes featuring business information for monitoring and providing real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); business consulting services provided to pharmaceutical industry clients involved in Phase I, II and III trials; business feasibility study planning, namely, for clinical trials; business study data interpretation, namely, for clinical trials; business consulting and management in the field of clinical trials, namely, site selection, study design, rater training, data analysis and reporting (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, video enhancement of rater interviewing for independent evaluation data (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).,Training of site staff in administering medicine and testing, completing patient documentation, and using technology, in the field of pharmaceutical studies; provision of a website featuring temporary online non-downloadable publications in the nature of reports, articles and presentations in the fields of clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); provision of temporary online non-downloadable educational webinars in the field of clinical trials.,Providing temporary use of non-downloadable software and applications for use in database management and support for use in data collection in connection with clinical trials; medical and scientific research, data collection and data analysis in the nature of clinical research and clinical trials in the fields of health care, medical care and pharmaceutical use; provision of an internet based database for data entry and management, electronic approval and audit trail capture in the field of pharmaceutical research and development purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture to conduct clinical trials for pharmaceutical research and development purposes featuring scientific research information on complex statistical techniques, programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture for pharmaceutical research and development purposes designed to monitor and provide real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing an internet based database for data entry and management, electronic approval and audit trail capture to conduct clinical trials in the field of clinical trials for pharmaceutical research and development purposes featuring scientific research information for monitoring and providing real-time feedback and guidance related to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); provision of platforms on the internet relating to the field of clinical trials; provision of temporary online non-downloadable computer programs for data entry and management, electronic approval and audit trail capture in data networks relating to the fields of clinical trials; design and development of computer software relating to the field of clinical trials; maintenance and updating of computer software relating to the field of clinical trials; provision of a web site for internet storage space, namely, to store data relating to clinical trials (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); data administration on servers relating to clinical trials data (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); application service provider (ASP), namely, hosting computer software applications for others, namely, for clinical trials; providing a website featuring technology that enables patients to upload and publicly share data from blood sugar meters for diabetes management purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); computer services, namely, provision of search platforms in the nature of temporary online non-downloadable software to manage diabetes management data; computer services, namely, provision of platforms on the Internet in the nature of temporary non-downloadable software to manage data on diabetes management; software as a service (SAAS) services featuring software for hosting, managing, and transmitting patient data and communicating with patients via video consults, messaging and surveys; software as a service (SAAS) services featuring software for capturing medical data from patients for the purpose of remote patient monitoring and care coordination; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes on computing devices including handhelds, PDAs, web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinician and observer reported outcomes on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for interfacing and integrating with third party clinical systems to enable transferring, collecting, viewing, and sharing of clinical study data; providing a website featuring blogs, reports, articles and presentations in the fields of clinical trials; software as a service (SAAS) services featuring software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, all of which information is added to existing study questionnaires as a way to record concomitant medications (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinical outcomes assessments on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for conveying to patients information related to a clinical trial using interactive multimedia and for enabling patients to dynamically engage, review, question and agree to participate in a clinical trial, featuring tiered information delivery, interactive assessments, interactive communication of questions to the clinical trial staff, and to generate information and reports, and featuring a development platform allowing users to collaboratively design and develop content across multiple stakeholders; software as a service (SAAS) services featuring software for processing and presenting patient data; software as a service (SAAS) services featuring software for enabling patients to enroll in a clinical study; software as a service (SAAS) services featuring software for enabling users to view, manage and report on patient reported data in pharmaceutical industry clinical trials; software as a service (SAAS) services featuring software for the development, design, localization and simulation of electronic clinical outcome assessments for pharmaceutical industry clinical trials; consulting services in the design and implementation of computer based information systems related to clinical trial and supply management; consulting services in the design and implementation of computer based information systems in connection with clinical research and clinical trials; computer software development and computer software consulting services for use in the fields of pharmaceutical research, biotechnology, clinical trials and supply management; scientific study planning in the field of clinical trials; rental services relating to data processing equipment and computers for use in clinical studies; scientific study data analysis in the field of pharmaceuticals; medical and scientific research, namely, collecting, monitoring and evaluating patient and clinical data; temporary online non-downloadable communication software, pharmaceutical industry clinical trial software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information, including patient reported outcomes and clinical outcomes assessments, on computing devices (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).
基礎出願番号98301482
基礎出願日2023-12-06
基礎出願国US
出願人Signant Health Global LLC
OCRテキストSITINANT
OCRテキスト2
OCRについて

関連商標